Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014-2016 Ebola outbreak in West Africa.
Sign Up to like & getrecommendations! Published in 2017 at "Vaccine"
DOI: 10.1016/j.vaccine.2016.11.093
Abstract: To better understand the association between Ebola-related attitudes and interest in receiving an Ebola virus vaccine, a survey was administered to a U.S. national sample using GfK's KnowledgePanel®. Among participants (N=1417), 34.1% expressed interest in… read more here.
Keywords: national sample; ebola vaccine; ebola; interest ... See more keywords
Ebola vaccine approved for use in ongoing outbreak
Sign Up to like & getrecommendations! Published in 2017 at "Nature"
DOI: 10.1038/nature.2017.22024
Abstract: Officials have signed off on an experimental vaccine in the Democratic Republic of the Congo, but the decision on whether to deploy it remains up in the air. read more here.
Keywords: vaccine approved; use ongoing; ebola vaccine; vaccine ... See more keywords
‘We will soon be dead’: stigma and cascades of looping effects in a collaborative Ebola vaccine trial
Sign Up to like & getrecommendations! Published in 2019 at "Critical Public Health"
DOI: 10.1080/09581596.2019.1682124
Abstract: ABSTRACT Can the careful implementation of global health research reduce the stigmatization of involved human subjects? This study analyses stigma in an Ebola vaccine clinical trial in West Africa that deployed complex community engagement strategies… read more here.
Keywords: trial; looping effects; ebola vaccine; soon dead ... See more keywords
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa
Sign Up to like & getrecommendations! Published in 2017 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.aaj1701
Abstract: A specific plasma signature reveals the critical role of monocytes in the VSV-vectored Ebola vaccine immunogenicity and safety. Monocytes make their mark in Ebola vaccination A VSV-vectored Ebola vaccine was used in Guinea during the… read more here.
Keywords: plasma; immunogenicity; safety; ebola vaccine ... See more keywords
WHO ready to deploy Ebola vaccine in disease outbreak
Sign Up to like & getrecommendations! Published in 2017 at "British Medical Journal"
DOI: 10.1136/bmj.j2454
Abstract: For the first time during a live outbreak of Ebola, a vaccine could be used to stop the spread of the disease, the World Health Organization has said. In a press briefing on 18 May,… read more here.
Keywords: ready deploy; disease; ebola vaccine; vaccine ... See more keywords
Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
Sign Up to like & getrecommendations! Published in 2021 at "BMC Medical Ethics"
DOI: 10.1186/s12910-021-00606-6
Abstract: Background Little is known about volunteers from Northern research settings who participate in vaccine trials of highly infectious diseases with no approved treatments. This article explores the motivations of HIV immunocompromised study participants in Canada… read more here.
Keywords: clinical trial; participation; trial; study ... See more keywords
Willingness-to-pay for a hypothetical Ebola vaccine in Indonesia: A cross-sectional study in Aceh.
Sign Up to like & getrecommendations! Published in 2019 at "F1000Research"
DOI: 10.12688/f1000research.20144.1
Abstract: Background: Some Ebola vaccines have been developed and tested in phase III clinical trials. However, assessment of whether public have willingness to purchase or not, especially in unaffected areas, is lacking. The aim of this… read more here.
Keywords: pay; study; hypothetical ebola; ebola vaccine ... See more keywords